^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Multiple Myeloma |
| Drug: | zoledronic acid (Bone resorption factor inhibitor, Osteoclast inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Excerpt:
Zometa is a bisphosphonate indicated for the treatment of:…Patients with multiple myeloma and patients with documented bone metastases from solid tumors, in conjunction with standard antineoplastic therapy.
